Getting to know the enemy better—the global burden of chronic kidney disease

Kidney International

Volumn 94, Issue 3, 2018, Pages 462-464

  Jha, Vivekanand ^a,b   Modi, Gopesh K ^c  

^a GEORGE INSTITUTE FOR GLOBAL HEALTH   (Australia)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c Samarpan Kidney Center   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC KIDNEY FAILURE; GLOBAL DISEASE BURDEN; HUMAN; INCIDENCE; LIFE EXPECTANCY; MORTALITY RATE; NOTE; POPULATION RISK; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; DISABLED PERSON; GLOBAL HEALTH; QUALITY ADJUSTED LIFE YEAR;

DISABLED PERSONS; GLOBAL BURDEN OF DISEASE; GLOBAL HEALTH; HUMANS; QUALITY-ADJUSTED LIFE YEARS; RENAL INSUFFICIENCY, CHRONIC;

EID: 85053844554     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1016/j.kint.2018.05.009     Document Type: Note

References (9)

1. GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390 (2017), 1151–1210.
2. Eckardt, K.U., Bansal, N., Coresh, J., et al. Improving the prognosis of patients with severely decreased glomerular filtration rate (CKD G4+): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int 93 (2018), 1286–1292.
3. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 385 (2015), 117–171.
4. Xie, Y., Bow, B., Mokdad, A.H., et al. Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016. Kidney Int 94 (2018), 567–581.
5. Mills, K.T., Xu, Y., Zhang, W., et al. A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int 88 (2015), 950–957.
6. Hill, N.R., Fatoba, S.T., Oke, J.L., et al. Global prevalence of chronic kidney disease—a systematic review and meta-analysis. PLoS One, 11, 2016, e0158765.
7. Delanaye, P., Glassock, R.J., De Broe, M.E., Epidemiology of chronic kidney disease: think (at least) twice!. Clin Kidney J 10 (2017), 370–374.
8. Liyanage, T., Ninomiya, T., Jha, V., et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet 385 (2015), 1975–1982.
9. Wei, S.Y., Chang, Y.Y., Mau, L.W., et al. Chronic kidney disease care program improves quality of pre-end-stage renal disease care and reduces medical costs. Nephrology (Carlton) 15 (2010), 108–115.